CELLF BIO achieved a major milestone with the world’s first human implantation of BioSphincter™, an autologous bioengineered sphincter made of smooth muscle and differentiated neural stem cells. The Phase 1...

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases, will present the first set of clinical data from its lead asset, ZB131, directed against...

Consumers are increasingly in pursuit of healthier diets, including plant-based diets, Mediterranean-style diets, and ones high in fiber. Along with these diet changes, though, can come digestive distress from specific...

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in...

Governor Glenn Youngkin today announced that AgroSpheres, a leader in developing the next generation of environmentally friendly crop health products, will invest $25 million to expand in Albemarle County. The...

A Parkinson’s disease (PD) study partially funded by the Foundation and led by Prof. José Obeso at HM CINAC in Madrid, Spain, used focused ultrasound plus microbubbles to deliver gene...

Springbok Analytics, which uses AI to convert 2D MRI scans into a 3D digital twin for muscle analysis, has completed an oversubscribed $3 million seed round led by Transition Equity...

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases, will present new, preclinical data showing that its lead asset, ZB131, directed against cancer-specific plectin...

Baltimore-based CraniUS inked a strategic partnership deal with Philadelphia-based Medical Product Laboratories (MPL). A CraniUS spokesperson told BioBuzz that it is developing a fully embedded, fully implantable wireless medical device to allow long-term drug...

Breast cancer. Cervical cancer. Ovarian cancer. Uterine cancer. Like many cancers that are out there, we’ve made tremendous progress in how we think about and treat women’s cancers. We’re able...

Virginia life sciences entrepreneur Josep Bassaganya-Riera’s latest company NImmune Biopharma launched with an eye on a potential New Drug Application for its Phase III-ready experimental therapeutic for ulcerative colitis. NImmune Biopharma’s lead...

Hong Chen, PhD, her co-senior author Arash Nazeri, MD, an assistant professor of radiology at the School of Medicine’s Mallinckrodt Institute of Radiology, and their research team at Washington University...